US Judge rejects Altria-Juul settlement proposal
According to a report by Law360, a U.S. federal judge has denied preliminary approval of a $117 million settlement proposal between Altria Group and its shareholders regarding the company's investment in Juul Labs, stating that the proposed deal is "inadequate".
Photo: steheap. The lawsuit argues that in 2018, executives of Altria acted cautiously when they acquired a 35% stake in Juul for $12.8 billion.
According to shareholders, Altria executives are engaging in illegal and anti-competitive practices that have resulted in the loss of billions of dollars for the company. This is due to the increasing legal battles Juul is facing, as its products are suspected to pose a health risk and the company is alleged to have marketed to underage consumers. The plaintiffs argue that Altria was aware of this issue when investing, but chose to overlook it.
As Juul Labs faces increased litigation and regulatory scrutiny, the investment value of Altria has steadily declined.
The plaintiff argues for the approval of a settlement, stating that it is fair and reasonable to recover the cost and risk of further litigation. U.S. District Judge David J. Novak has not explained why he finds the settlement inadequate.
Statement:
This article is compiled from third-party information and is intended solely for industry communication and learning.
This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness and accuracy of the article's content. The compilation of this article is only intended for industry communication and research.
Due to limitations in our translation capabilities, the translated article may not fully reflect the original text. Please refer to the original text for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related expressions or stances.
Copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us to have it removed.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
